Loeb N, Andrew MK, Loeb M, et al. Frailty Is Associated With Increased Hemagglutination-Inhibition Titers in a 4-Year Randomized Trial Comparing Standard- And High-Dose Influenza Vaccination. Open Forum Infect Dis. 2020;7(5):ofaa148.
Methods: We conducted a randomized, double-blind trial (2014/2015 to 2017/2018) of SD versus HD trivalent split-virus vaccine (Fluzone) in 612 study participants aged 65+ over 4 influenza seasons. Hemagglutination inhibition antibody titers for influenza H1N1, H3N2, and B vaccine subtypes were measured at baseline and at 4, 10, and 20 weeks postvaccination and frailty was measured using a validated frailty index.
Results: Geometric mean antibody titers were significantly higher in HD compared with SD vaccine recipients for all influenza subtypes at all time points postvaccination. However, frailty was positively correlated with 4-week titers and was associated with increased odds of being a vaccine responder. For influenza A subtypes, this was mostly limited to HD recipients.
Conclusions: Frailty was associated with higher titers and increased antibody responses at 4 weeks after influenza vaccination, which was partially dependent on vaccine dosage. Chronic inflammation or dysregulated immunity, both of which are commonly observed with frailty, may be responsible, but it requires further investigation.
- Investigating the potential sequence variation in the influenza A matrix genes during the 2018-2019 season in samples from a local population in London 2 days ago
- Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children 2 days ago
- Identification of Efficacious Vaccines Against Contemporary North American H7 Avian Influenza Viruses 3 days ago
- Antibody Response of an H9 Subtype Avian Influenza Poultry Vaccine on Three Kinds of Wild Birds in Shanghai Zoo 3 days ago
- H7N1 Low Pathogenicity Avian Influenza Viruses in Poultry in the United States During 2018 3 days ago